Showing 17,221 - 17,240 results of 44,775 for search '(( 50 ((026 decrease) OR (a decrease)) ) OR ( 5 ((ng decrease) OR (mean decrease)) ))', query time: 1.08s Refine Results
  1. 17221

    B[a]P treatment results in modulation of intracellular phosphop38 MAP kinase. by Kallol Dutta (215291)

    Published 2010
    “…Similarly, phosphoP38 MAP kinase level in 0.2 µM B[a]P treated group after 24 h, was significantly decreased as compared to that in 12 h post treatment group. …”
  2. 17222
  3. 17223

    Knockdown of nr2f1a causes defects in zebrafish vascular development. by Bao-Jueng Wu (621818)

    Published 2014
    “…At the same stage ISVs are stalled at mid-somite in nr2f1a<sup>e2i2</sup> morphants (<b>D, F</b>). (<b>I</b>) Quantification of percentage of completed ISV shows a50% increase compared to <i>nr2f1a</i> morphants (n = 26 in wt and n = 34 in nr2f1aMO) at 30 hpf. …”
  4. 17224

    Parity and Pancreatic Cancer Risk: A Dose-Response Meta-Analysis of Epidemiologic Studies by Hong-Bo Guan (464993)

    Published 2014
    “…</p><p>Conclusion</p><p>In summary, these findings suggest that higher parity is associated with a decreased risk of PC. Future large consortia or pooled studies are warranted to fully adjust for potential confounders to confirm this association.…”
  5. 17225
  6. 17226

    S2 Data - by Tamara Mogilevski (14239682)

    Published 2024
    “…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
  7. 17227

    Study protocol. by Tamara Mogilevski (14239682)

    Published 2024
    “…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
  8. 17228

    S1 Data - by Tamara Mogilevski (14239682)

    Published 2024
    “…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
  9. 17229
  10. 17230
  11. 17231
  12. 17232
  13. 17233

    Antioxidant Carbocysteine Treatment in Obstructive Sleep Apnea Syndrome: A Randomized Clinical Trial by Kang Wu (160544)

    Published 2016
    “…The CPAP group also showed a decreased oxygen desaturation index and a significant increase in the mean oxygen saturation after treatment, but these increases were not observed in the carbocysteine group. …”
  14. 17234

    Chronic treatment with carvacrol improves passive avoidance memory in a rat model of Parkinson's disease by Hossein Haddadi (4895290)

    Published 2018
    “…The 6-OHDA-lesioned rats showed contralateral rotations towards the lesion side, which was accompanied by learning and memory deficits in a passive avoidance test and a decrease in tail withdrawal latency in a tail flick test at the end of week 6. …”
  15. 17235

    Vibration–induced enhancement of stick balancing skill as a function of vibration-induced amplitude lowering. by John G. Milton (223908)

    Published 2013
    “…Data is obtained from three subjects using three different vibration frequencies (15 Hz, 25 Hz, 50 Hz) on three different days. Relative survival is the same as defined in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007427#pone-0007427-g003" target="_blank">Figure 3</a>. …”
  16. 17236

    PAMAM-DEN<sup>CYS</sup> induces trafficking of ΔF508-CFTR to plasma membrane in CF cells. by Scott Mackenzie Brockman (4433614)

    Published 2017
    “…(A, right panel; C) Immunoblotting of total protein extracts from CFBE41o- cells treated with PAMAM-DEN or PAMAM-DEN<sup>CYS</sup> shows a significant increase in ‘C form’ (p<0.05) in PAMAM-DEN<sup>CYS</sup> treated cells. …”
  17. 17237

    Image3_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpeg by Heather A. Ogana (11774297)

    Published 2023
    “…Therefore, we evaluated four compounds (827171, 827032, 826941, and 825226), previously generated from a large Artemis targeted drug screen. A biochemical assay using a purified Artemis:DNA-PKcs complex shows that the Artemis inhibitors 827171, 827032, 826941, 825226 have nanomolar IC50 values for Artemis inhibition. …”
  18. 17238

    Image1_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpg by Heather A. Ogana (11774297)

    Published 2023
    “…Therefore, we evaluated four compounds (827171, 827032, 826941, and 825226), previously generated from a large Artemis targeted drug screen. A biochemical assay using a purified Artemis:DNA-PKcs complex shows that the Artemis inhibitors 827171, 827032, 826941, 825226 have nanomolar IC50 values for Artemis inhibition. …”
  19. 17239

    HBV Infection in Relation to Consistent Condom Use: A Population-Based Study in Peru by Antonio Bernabe-Ortiz (90790)

    Published 2011
    “…Consistent condom use was associated with decreased risk of anti-HBc. Findings from this study emphasize the need of primary prevention programs (vaccination) especially in the jungle population, and imply that condom use promotion might be a potential strategy to prevent HBV infection.…”
  20. 17240

    Granulocyte Colony-Stimulating Factor Reduces Fibrosis in a Mouse Model of Chronic Pancreatitis by Wey-Ran Lin (615284)

    Published 2014
    “…We aimed to test the effect of G-CSF on fibrosis in a mouse model of CP.</p><p>Methods</p><p>CP was induced in C57Bl/6J mice by consecutive cerulein injection (50 µg/kg/day, 2 days a week) for 6 weeks. …”